Pableo, Mary Mae .

HRN: 22-66-40  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2026
CEFTRIAXONE 1G (VIAL)
05/03/2026
05/10/2026
IV
2 Grams
Q24
Cap MR
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Pneumonia    Compliance to guidelines: